tirzepatide and crohn's Patients with stable inflammatory bowel disease (IBD) comorbid obesity and/or diabetes who started GLP-1 receptor agonists (semaglutide or tirzepatide) alongside ongoing treatment did not have a lower risk for the relapse Gut Hormones and Inflammatory Bowel

Messenger RNA Modifications: Form, Distribution, and Function

GLP-1s, the Brain, and Food Noise GLP-1 receptor agonists seem to help reduce food noise by reducing hunger signaling and increasing satiety, says Chris Esposito, DO, a bariatric surgeon at Northwells Staten Island University Hospital in New York

Methionine: Helps break down sugars & carbohydrates and convert to energy

Importantly, tirzepatide carries a boxed warning for risk of thyroid C-cell tumors and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN2)

Overweight and obesity in adults NHS

Each has its place